AQW 12585/22-27 Written question to the Minister of Health
To ask the Minister of Health (i) for an update on the Strategic Planning and Performance Group's evaluation of the NI PEARS Plus initiative; and (ii) to detail the anticipated date for the evaluation report to be published.
Asked by Danny Donnelly MLA on 28 May 2024
- Answered
- Written
- Tabled
- 28 May 2024
- Answer due by
- 12 June 2024
- Answered
- 11 June 202414 days after tabling
- Department
- Department of Health
- Priority question
- No
Answer
The Northern Ireland Primary Eyecare Assessment and Referral Service Plus (NI PEARS Plus) pilot commenced in 2023/24 and ran for thirty-three weeks, with 834 patients accessing the community optometry-based service with acute eye conditions which would otherwise have presented at Belfast HSC Trust Eye Casualty.
NI PEARS Plus seeks to build on the successful NI PEARS scheme which currently manages ca. 4,000 patients in community optometry settings, closer to home.
As per commissioning specification, the pilot is currently being evaluated for impact, assessing metrics around activity, performance, clinical safety, patient experience and cost-effectiveness.
The clinical safety element has been delayed by the work required within BHSCT to prepare for the implementation of encompass but it is expected that the data from the review of the clinical records will be with SPPG to allow the evaluation to be released by end of June 2024.
i) Following evaluation, and in consultation with stakeholders, Strategic Planning and Performance Group (SPPG) will make a commissioning decision on whether the service should be mainstreamed and introduced regionally, subject to available funding.
ii) From the initial data analysis approx. 25 patients per week were diverted from BHSCT Eye Casualty to the NIPEARS Plus service thus releasing capacity in Eye Casualty. Approximately 93% of these patients were managed to completion in primary care with approx. 7% subsequently requiring referral back into Eye Casualty as deemed too complex to be managed in primary care.
These figures are subject to validation, and the management and outcomes audited for quality and safety. Any subsequent regional roll-out would be expected to have scaled positive impact on waiting lists and times for acute eye care.